Singapore legislation

Regulation 2

of Healthcare Services (Nuclear Medicine Service) Regulations 2023

Regulation 2

Definitions

Subregulation 1

In these Regulations —

Definition

“calendar day” includes Saturday, Sunday and every public holiday;

Definition

“diagnostic radiographer” means a duly qualified allied health professional who is registered under the Allied Health Professions Act 2011 to practise radiography;

Definition

“duly qualified allied health professional” has the meaning given by section 3 of the Allied Health Professions Act 2011;

Definition

“examination” means a radiological examination of an individual conducted by a licensee at any approved permanent premises of the licensee;

Definition

“General Regulations” means the Healthcare Services (General) Regulations 2021 (G.N. No. S 1035/2021);

Definition

“imaging modality” means any imaging modality set out in paragraph 1 of the Schedule;

Definition

“in vivo assay procedure” means all of the following activities carried out by a licensee at any approved permanent premises of the licensee:

(a)

any process relating to the preparation, dispensing, radiolabelling, compounding and quality control of radiopharmaceuticals;

(b)

the administration of radiopharmaceuticals to a patient;

(c)

the derivation, after the administration of radiopharmaceuticals, of any specimen from the patient;

Definition

“irradiating apparatus”, “nuclear medicine service”, “radioactive material”, “radiopharmaceutical” and “simple in vitro diagnostic test” have the meanings given by paragraph 2 of the First Schedule to the Act;

Definition

“licensee” means a person who holds a licence to provide a nuclear medicine service;

Definition

“nuclear medicine imaging”, in relation to a nuclear medicine service, means the specified service for that service set out in paragraph 1 of the Schedule;

Definition

“nuclear medicine physician” means an individual who is registered under section 22 of the Medical Registration Act 1997 as a specialist in the branch of nuclear medicine;

Definition

“nuclear medicine technologist” means an individual who holds at least a diploma or degree in nuclear medicine technology, radiation therapy or radiography;

Definition

“personnel”, in relation to a licensee, means an individual employed or engaged by the licensee to assist the licensee in providing a nuclear medicine service;

Definition

“radiation safety officer” —

(a)

where a licensee uses any irradiating apparatus within the meaning given by regulation 2(1) of the Radiation Protection (Non‑Ionising Radiation) Regulations (Rg 1) — means an individual who is appointed by the licensee under regulation 40 of those Regulations as a radiation safety officer; or

(b)

in any other case — means an individual who is appointed by a licensee under regulation 19 of the Radiation Protection (Ionising Radiation) Regulations 2023 (G.N. No. S 85/2023) as a radiation safety officer or deputy radiation safety officer;

Definition

“radiation therapist” means a duly qualified allied health professional who is registered under the Allied Health Professions Act 2011 to practise radiation therapy;

Definition

“radioactive substance” has the meaning given by section 2(1) of the Radiation Protection Act 2007;

Definition

“requestor”, in relation to an examination, means a dentist or medical practitioner who ordered the examination for the patient;

Definition

“specimen” means any matter derived, obtained or excreted from the body of a patient for use in, or in connection with, the provision of a nuclear medicine service.

Subregulation 2

For the purposes of these Regulations —

(a)

a nuclear medicine service is provided for an imaging purpose where the service is provided, through the use of an irradiating apparatus, for either of the following purposes:

(i)

the medical diagnosis of an individual;

(ii)

the monitoring of the effects of medical therapy on an individual;

(b)

a nuclear medicine service is provided for an in vivo assay purpose where the service is provided to enable or facilitate either of the following through the use of an assay:

(i)

the medical diagnosis of an individual;

(ii)

the monitoring of the effects of medical therapy on an individual; and

(c)

a nuclear medicine service is provided for a therapy purpose where the service is provided for the purpose of treating an ailment, or a condition, disease or disorder or an injury affecting any part of the body or mind of an individual.